Why the study?
Heart failure hospitalisation predicts mortality in HFrEF, but there is little evidence analysing the impact of the number of previous heart failure admissions.
Does having ≥2 previous heart failure admissions worsen the prognosis regarding hospital readmissions and cardiovascular mortality in patients with HFrEF?
Does having ≥2 previous heart failure admissions worsen the prognosis regarding hospital readmissions and cardiovascular mortality in patients with HFrEF?
Answers are grounded in this paper and cite their sources.
In patients with HFrEF, having ≥2 previous heart failure admissions is associated with a higher burden of comorbidities, worse reverse remodeling, and significantly higher rates of subsequent HF readmission and cardiovascular mortality.
Background: Worsening heart failure (WFH) includes heart failure (HF) hospitalisation, representing a strong predictor of mortality in patients with heart failure with reduced ejection fraction (HFrEF). However, there is little evidence analysing the impact of the number of previous HF admissions. Our main objective was to analyse the clinical profile according to the number of previous admissions for HF and its prognostic impact in the medium and long term. Methods: A retrospective study of a cohort of patients with HFrEF, classified according to previous admissions: cohort-1 (0–1 previous admission) and cohort-2 (≥2 previous admissions). Clinical, echocardiographic and therapeutic variables were analysed, and the medium- and long-term impacts in terms of hospital readmissions and cardiovascular mortality were assessed. A total of 406 patients were analysed. Results: The mean age was 67.3 ± 12.6 years, with male predominance (73.9%). Some 88.9% (361 patients) were included in cohort-1, and 45 patients (11.1%) were included in cohort-2. Cohort-2 had a higher proportion of atrial fibrillation (49.9% vs. 73.3%; p = 0.003), chronic kidney disease (36.3% vs. 82.2%; p < 0.001), and anaemia (28.8% vs. 53.3%; p = 0.001). Despite having similar baseline ventricular structural parameters, cohort-1 showed better reverse remodelling. With a median follow-up of 60 months, cohort-1 had longer survival free of hospital readmissions for HF (37.5% vs. 92%; p < 0.001) and cardiovascular mortality (26.2% vs. 71.9%; p < 0.001), with differences from the first month. Conclusions: Patients with HFrEF and ≥2 previous admissions for HF have a higher proportion of comorbidities. These patients are associated with worse reverse remodelling and worse medium- and long-term prognoses from the early stages, wherein early identification is essential for close follow-up and optimal intensive treatment.
No takes yet. Share an insight, caveat, or question.
Armijo et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: